Pepgen Inc (PEPG)

$4.57 +0.07 (1.56%)
Market Cap 147.60M
Revenue (ttm) 0.00
Net Income (ttm) -89.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 509,600
Avg Vol 4,127,656
Day's Range N/A - N/A
Shares Out 32.80M
Stochastic %K 28%
Beta 1.96
Analysts Strong Sell
Price Target $8.50

Company Profile

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 797 0979
Website: pepgen.com
Address:
321 Harrison Avenue, 8th Floor, Boston, United States
TalkMarkets
TalkMarkets Oct. 21 at 9:34 PM
The Right Way To Own Small Cap Stocks $GS $TXN $NVDA $RTX $PEPG https://talkmarkets.com/content/stocks--equities/the-right-way-to-own-small-cap-stocks?post=529649
0 · Reply
Anonymous10000
Anonymous10000 Oct. 19 at 9:06 PM
$PEPG if you want some excitement, check out $SLS tomorrow. Nice AH gain is the start of a run leading into the company announcement Oct. 29. Possible short squeeze!
0 · Reply
Parnell8
Parnell8 Oct. 14 at 5:56 PM
$PEPG 10:1 r/ r is great. If they really solved splice number pt are all way too low, $50 is possible
1 · Reply
optionsReasy
optionsReasy Oct. 13 at 5:22 PM
$PEPG 💩💩💩💩
0 · Reply
GoNoles2012
GoNoles2012 Oct. 10 at 3:17 PM
$PEPG I’m out. Too scared that it’ll free fall back to 2 or 3 dollars
0 · Reply
optionsReasy
optionsReasy Oct. 10 at 11:55 AM
$PEPG today is the day we pump and break out on the PR this weekend. Hopefully…
1 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 11:02 PM
Keep a close watch on CMCT! $AMBA $CHWY $INDP $PEPG 22
0 · Reply
boomshiva
boomshiva Oct. 9 at 11:39 AM
$PEPG Look out for a buying opp at the open. Bank of America PT raised to $3 (lol) and maintained Underperform rating.
1 · Reply
optionsReasy
optionsReasy Oct. 8 at 4:30 PM
$PEPG pumping so hard rn
0 · Reply
Jefcud
Jefcud Oct. 8 at 4:29 PM
$PEPG
0 · Reply
Latest News on PEPG
PepGen: DMD Discontinued, Ways To Go With DM1

Oct 7, 2025, 6:38 PM EDT - 17 days ago

PepGen: DMD Discontinued, Ways To Go With DM1

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society

Oct 2, 2025, 7:00 AM EDT - 23 days ago

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society

PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Sep 26, 2025, 4:01 PM EDT - 4 weeks ago

PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles

Sep 25, 2025, 9:46 AM EDT - 4 weeks ago

PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles

PepGen Announces Pricing of $100 Million Public Offering

Sep 24, 2025, 10:51 PM EDT - 4 weeks ago

PepGen Announces Pricing of $100 Million Public Offering

PepGen Announces Proposed Public Offering

Sep 24, 2025, 4:21 PM EDT - 4 weeks ago

PepGen Announces Proposed Public Offering

PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients

Sep 24, 2025, 4:16 PM EDT - 4 weeks ago

PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients

PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 7, 2025, 8:00 AM EDT - 2 months ago

PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Jul 30, 2025, 5:41 PM EDT - 3 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Jul 29, 2025, 10:33 AM EDT - 3 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Jul 23, 2025, 11:22 AM EDT - 3 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 8, 2025 in PepGen Inc. Lawsuit - PEPG

Jun 23, 2025, 9:00 AM EDT - 4 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 8, 2025 in PepGen Inc. Lawsuit - PEPG

Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein

Jun 16, 2025, 10:39 AM EDT - 4 months ago

Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein

PEPGEN INC. (NASDAQ: PEPG) INVESTOR ALERT Investors With Large Losses in PepGen Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jun 10, 2025, 10:44 AM EDT - 4 months ago

PEPGEN INC. (NASDAQ: PEPG) INVESTOR ALERT Investors With Large Losses in PepGen Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

PepGen Abandons Duchenne Program, Shifts Spotlight To Another Rare Disease Candidate

May 29, 2025, 9:19 AM EDT - 5 months ago

PepGen Abandons Duchenne Program, Shifts Spotlight To Another Rare Disease Candidate

PepGen to discontinue development of experimental Duchenne therapy; shares drop

May 28, 2025, 6:21 PM EDT - 5 months ago

PepGen to discontinue development of experimental Duchenne therapy; shares drop

PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update

May 28, 2025, 4:05 PM EDT - 5 months ago

PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update

PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer

May 20, 2025, 7:00 AM EDT - 5 months ago

PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer

PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 8, 2025, 8:00 AM EDT - 6 months ago

PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 2, 2025, 4:05 PM EDT - 7 months ago

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference

PepGen Announces Appointment of Two New Directors to its Board

Mar 31, 2025, 4:05 PM EDT - 7 months ago

PepGen Announces Appointment of Two New Directors to its Board

PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Mar 10, 2025, 4:05 PM EDT - 8 months ago

PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

PepGen To Voluntarily Pause Mid-Stage Duchenne Muscular Dystrophy Study, Stock Falls

Mar 4, 2025, 1:41 PM EST - 8 months ago

PepGen To Voluntarily Pause Mid-Stage Duchenne Muscular Dystrophy Study, Stock Falls

PepGen to Participate in Upcoming Investor Conferences

Mar 4, 2025, 8:05 AM EST - 8 months ago

PepGen to Participate in Upcoming Investor Conferences

PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD

Mar 4, 2025, 8:00 AM EST - 8 months ago

PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD

PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights

Feb 24, 2025, 7:30 AM EST - 8 months ago

PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights

PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1

Feb 24, 2025, 7:00 AM EST - 8 months ago

PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1

TalkMarkets
TalkMarkets Oct. 21 at 9:34 PM
The Right Way To Own Small Cap Stocks $GS $TXN $NVDA $RTX $PEPG https://talkmarkets.com/content/stocks--equities/the-right-way-to-own-small-cap-stocks?post=529649
0 · Reply
Anonymous10000
Anonymous10000 Oct. 19 at 9:06 PM
$PEPG if you want some excitement, check out $SLS tomorrow. Nice AH gain is the start of a run leading into the company announcement Oct. 29. Possible short squeeze!
0 · Reply
Parnell8
Parnell8 Oct. 14 at 5:56 PM
$PEPG 10:1 r/ r is great. If they really solved splice number pt are all way too low, $50 is possible
1 · Reply
optionsReasy
optionsReasy Oct. 13 at 5:22 PM
$PEPG 💩💩💩💩
0 · Reply
GoNoles2012
GoNoles2012 Oct. 10 at 3:17 PM
$PEPG I’m out. Too scared that it’ll free fall back to 2 or 3 dollars
0 · Reply
optionsReasy
optionsReasy Oct. 10 at 11:55 AM
$PEPG today is the day we pump and break out on the PR this weekend. Hopefully…
1 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 11:02 PM
Keep a close watch on CMCT! $AMBA $CHWY $INDP $PEPG 22
0 · Reply
boomshiva
boomshiva Oct. 9 at 11:39 AM
$PEPG Look out for a buying opp at the open. Bank of America PT raised to $3 (lol) and maintained Underperform rating.
1 · Reply
optionsReasy
optionsReasy Oct. 8 at 4:30 PM
$PEPG pumping so hard rn
0 · Reply
Jefcud
Jefcud Oct. 8 at 4:29 PM
$PEPG
0 · Reply
optionsReasy
optionsReasy Oct. 8 at 2:02 PM
$PEPG 💩
0 · Reply
boomshiva
boomshiva Oct. 7 at 7:35 PM
$PEPG Back in at 4.96.
0 · Reply
optionsReasy
optionsReasy Oct. 6 at 6:37 PM
$PEPG one day $SPRB
0 · Reply
TraderJay85
TraderJay85 Oct. 5 at 10:50 PM
This week watch list with support/stop. $ATYR .75 stop $PEPG 5.00 stop $WOK .0750 stop $XXII 1.60 stop $GYRO 9.50 stop Never hold under support. if it goes below then sell. Jump back in if it comes back to last support. NO EMAILS NO DISCORDS JUST FREE IDEAS TO EVERYONE. HIT THE FOLLOW AND LETS MAKE MONEY TOGETHER ❤️
0 · Reply
HedgingHomer
HedgingHomer Oct. 5 at 4:57 PM
$PEPG Technology services growth. Testing resistance level. Volume expansion needed for continuation. Sector momentum.
1 · Reply
ibaian
ibaian Oct. 5 at 3:43 PM
$PEPG RA CAPITAL ADDED 9.3 MILLION SHARES
0 · Reply
ibaian
ibaian Oct. 5 at 3:41 PM
$PEPG VIKING GLOBAL 3.4 MILLION SHARES
0 · Reply
ibaian
ibaian Oct. 5 at 3:40 PM
$PEPG yes possible
0 · Reply
MothersMilkies
MothersMilkies Oct. 3 at 7:18 PM
$PEPG next week double
1 · Reply
optionsReasy
optionsReasy Oct. 3 at 2:45 PM
$PEPG $6 incoming
0 · Reply
GQTrit
GQTrit Oct. 3 at 2:18 PM
$MIST You guys crack me up. Anyway all proceeds went to $PEPG
1 · Reply
thezat
thezat Oct. 2 at 7:58 PM
$PEPG
0 · Reply